| ²é¿´: 3124 | »Ø¸´: 7 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
¡¾ÇóÖú¡¿·¢£¨£¨ºÜ¶à½ð±Ò£©£©ÇóÒ»¸öÐÂÒ©µÄÐÅÏ¢
|
|||
|
ÉÌÆ·Ãû£º Mepact ͨÓÃÃû£ºÃ×·¥Ä¾ëÄ(mifamurtide) ·Ö×Óʽ£º C59H109N6O19P CASµÇ¼ÇºÅ£º83461-56-7 2009Äê»ñÅ·ÃËÅú×¼ÉÏÊÐ Ç󣺴˻¯ºÏÎïµÄ 1.Àí»¯ÐÔÖÊ 2.ÖÆ¼Á¡¢´¦·½¡¢¹¤ÒÕ¼°·ÖÎö¼ì²â 3.Ò©Àí¡¢¶¾ÐÔ¡¢Ò©´ú ÓÐÀ´Ô´³ö´¦¸üºÃ£¬ÄÜÓжàÉپ͸ø¶àÉÙÐÅÏ¢£¬ ÒÑÓеľͿÉÒÔÁË£¬½áÊø£¬Ð»Ð»»Ø¸´ [ Last edited by wo668668 on 2011-1-2 at 23:52 ] |
» ²ÂÄãϲ»¶
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ65È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ1È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÇóÖúµç×Ӱ棺¾§ÐÍÒ©ÎïÑз¢ÀíÂÛÓëÓ¦ÓÃ
ÒѾÓÐ0È˻ظ´
±±¾©´óѧҩѧԺ³ÏÕÐÒ©Îﻯѧ/Óлú»¯Ñ§·½Ïò²©Ê¿ºó
ÒѾÓÐ5È˻ظ´
2027ҩѧ²©Ê¿ÉêÇë
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¡¾Ô´´¡¿¶à¸ö1ÀàÁÙ´²Ç°ÐÂҩѰÇóºÏ×÷ºÍתÈã¨DPP4,GLP-1,ÌæÄáÀàÁÙ´²Ç°Ð½ṹ£©
ÒѾÓÐ26È˻ظ´
¡¾ÇóÖú¡¿ÐÂÒ©Á¢ÏîÐÅÏ¢²éѯÈçºÎ²Ù×÷
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿Ò»¸ö»ºÊÍÆ¬ÔÚÌåÄÚ´ïµ½ÄÄЩҩ¶¯Ñ§²ÎÊý²ÅÄÜËã12h»ºÊÍ£¿
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚÒ»¸öÒ©Æ··¢²¹ÑÓÆÚµÄÎÊÌâ
ÒѾÓÐ7È˻ظ´
¡ï
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:49
wo668668(½ð±Ò+5): 2010-12-31 12:48:10
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:49
wo668668(½ð±Ò+5): 2010-12-31 12:48:10
|
Å·ÖÞÅú×¼Ã×·¥Ä¾ëÄ(mifamurtide)×¢Éä¼ÁÉÏÊÐ Å·ÖÞÅú×¼IDM Pharma¹«Ë¾µÄÃ×·¥Ä¾ëÄ×¢Éä¼Á£¨mifamurtide£¬L-MTP-PE£¬:Mepact£©ÉÏÊУ¬ÓÃÓÚÖÎÁÆ·Ç×ªÒÆÐÔ¿ÉÇгýµÄ¹ÇÈâÁö£¨ÉÙ¼ûµ«Ö÷ÒªÔì³É¶ùͯºÍÇàÄêËÀÍöµÄ¹ÇÁö£©¡£±¾Æ·ÊÇ20ÓàÄêÀ´Ê׸ö»ñ×¼ÉÏÊÐÖÎÁƹÇÈâÁöµÄÐÂÒ©¡£±¾Æ·¿ÉÔÚÅ·ÃË27¸ö³ÉÔ±¹úÒÔ¼°±ùµº¡¢ÁÐÖ§¶ØÊ¿µÇºÍŲÍþÏúÊÛ¡£ Ã×·¥Ä¾ëÄÊÇ20ÓàÄêÀ´Ê׸ö¸ÄÉÆ¹ÇÈâÁö»¼Õß³¤ÆÚ´æ»îµÄÒ©Æ·¡£»¼ÕßÊõǰ»¯ÁÆ£¬ËæºóÊÖÊõÇгý¹ÇÁö£¬¶øºóÔÙ»¯ÁÆ¡£µ±»¼Õß½ÓÊÜÊõºó»¯ÁƵÄͬʱҲ¾²Âö×¢Éä×¢É䱾ƷÃâÒßÖÎÁÆ£¨Ò»ÖÜ2´Î£¬3¸öÔ£¬ËæºóÒ»ÖÜ1´Î£¬6¸öÔ£©¡£»¯ÁÆÈçͬըµ¯´Ý»ÙÖ×Áö£¬¶øÃ×·¥Ä¾ëÄÈçͬħ²ù¿É³¹µ×Çå³ý¼²²¡ÏÔ΢սº¾ÄڵIJÐÁôÎï¡£ Ã×·¥Ä¾ëÄͨ¹ý´Ì¼¤ÖîÈç¾ÞÊÉϸ°ûµÈijЩ°×ϸ°ûÀ´É±ÃðÖ×Áöϸ°û¡£±¾Æ·ÖƳÉÇòÐÎÖ¬ÖÊÌ壬ÄÒÅÝÄÚÊǰû±Úõ£ÈýëÄ£¨MTP£©¡£´ËÖ¬ÖÊ´¥·¢¾ÞÊÉϸ°ûÈ¥ÏûºÄÃ×·¥Ä¾ëÄ¡£Ò»µ©ÏûºÄÍ꣬MTP´Ì¼¤ÓÈÆäÊÇÔڸΡ¢Æ¢ºÍ·ÎÄڵľÞÊÉϸ°ûȥѰÕÒÖ×Áö²¢É±ÃðÖ®¡£ Ã×·¥Ä¾ëÄ×¢Éä¼Á»ñ×¼ÉÏÊлùÓÚ¢óÆÚÁÙ´²Ñо¿½á¹û¡£¹úÁ¢°©Ö¢Ñо¿Ëù£¨NCI£©½¨Á¢µÄÐ×÷×飬ÓɶùͯÖ×Áö×飨COG£©½øÐÐÑо¿£¬Íê³É±¾Æ·ÖÎÁƹÇÈâÁö×î´óÑо¿¿ÎÌâÔÚ²áµÄ»¼ÕßÔ¼800Àý¡£Ñо¿ÆÀ¼ÛÁËÃ×·¥Ä¾ëÄÓë3¡«4ÖÖ¸¨Öú»¯ÁÆÒ©£¨Ë³²¬¡¢¶àÈá±ÈÐÇ¡¢¼×°±µûßÊ¡¢ÓлòÎÞÒì»·Á×õ£°·£©ÁªºÏÓÃÒ©µÄ½á¹û¡£Ñо¿ÏÔʾ£¬Ã×·¥Ä¾ëÄÓ뻯ѧҩÎïÁªºÏʹÓÿÉʹËÀÍöÂʽµµÍÔ¼30%£¬78&¾ÖÎÁƵϼÕß´æ»î³¤´ï6ÄêÒÔÉÏ¡£ |
4Â¥2010-12-31 08:57:54
yalefield
½ð³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 129 (¸ßÖÐÉú)
- ¹ó±ö: 0.17
- ½ð±Ò: 21238.9
- Ìû×Ó: 12101
- ÔÚÏß: 759.1Сʱ
- ³æºÅ: 96063
¡ï
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:37
wo668668(½ð±Ò+10): 2010-12-31 12:52:08
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:37
wo668668(½ð±Ò+10): 2010-12-31 12:52:08
|
Systematic (IUPAC) name 2-[(N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]-propanoyl}-L-alanyl-D-isoglutaminyl-L-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate Identifiers CAS number £¨1£©83461-56-7 £¨2£©838853-48-8 (mifamurtide sodium ¡¤ xH2O) Chemical data Formula C59H109N6O19P Mol. mass 1237.499 g/mol SMILES eMolecules & PubChem Pharmacokinetic data Bioavailability N/A Half-life minutes (in plasma) 18 hrs (terminal) Therapeutic considerations Licence data EMA:Link Pregnancy cat. not investigated Legal status ℞ Prescription only Routes intravenous liposomal infusion over one hour muramylNAc-Ala-isoGln-Lys-tripeptide-PE Pharmacological Action Adjuvants, Immunologic [Link to MeSH] - Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The ... [show more] Adjuvants, Immunologic [Link to MeSH] - Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. [show less] Immunologic Factors [Link to MeSH] - Biologically active substances whose activities affect or play a role in the functioning of the immune system. Pharmacological Classification Chemical Actions and Uses [Link to MeSH] Pharmacologic Actions [Link to MeSH] Physiological Effects of Drugs [Link to MeSH] Immunologic Factors [Link to MeSH] Adjuvants, Immunologic [Link to MeSH] |
2Â¥2010-12-31 03:22:36
¡ï
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:42
wo668668(½ð±Ò+10): 2010-12-31 12:49:24
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:42
wo668668(½ð±Ò+10): 2010-12-31 12:49:24
|
¿ÉÒԲο¼Ò»ÏÂwiki°Ù¿Æ http://en.wikipedia.org/wiki/Mifamurtide |
3Â¥2010-12-31 08:54:24
¡ï
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:55
wo668668(½ð±Ò+5): 2010-12-31 12:52:37
warlen(½ð±Ò+1):лл²ÎÓë 2010-12-31 09:40:55
wo668668(½ð±Ò+5): 2010-12-31 12:52:37
|
¶¾Àíѧ£º¼±ÐÔ¶¾ÐÔÊý¾Ý¿â http://www.cerc.usgs.gov/data/acute/acute.html »¯ºÏÎï¶¾ÐÔÏà¹ØÊý¾Ý¿â Toxnet http://toxnet.nlm.nih.gov/ »¯Ñ§Ò©ÎïÊý¾Ý¿â£º»¯Ñ§Êý¾Ý¿â NISTµÄChemistry WebBook http://webbook.nist.gov/chemistry/ ËüÊÇÃÀ¹ú¹ú¼Ò±ê×¼Óë¼¼ÊõÑо¿ÔºNISTµÄ»ùÓÚWebµÄÎïÐÔÊý¾Ý¿â£¬Chemistry WebBook¿ÉÒÔ¿´×÷ÊÇNISTµÄ±ê×¼²Î¿¼Êý¾Ý¿âStandard Reference DataÖÐÒ»²¿·ÖÓ뻯ѧÓйصÄÊý¾Ý¿âµÄWeb°æ±¾£¬¿Éͨ¹ý·Ö×Óʽ¼ìË÷¡¢»¯Ñ§Ãû¼ìË÷¡¢CAS µÇ¼ºÅ¼ìË÷¡¢Àë×ÓÄܼìË÷¡¢µç×ÓÇ׺ÍÁ¦¼ìË÷¡¢ÖÊ×ÓÇ׺ÍÁ¦¼ìË÷¡¢Ëá¶È¼ìË÷¡¢±íÃæ»î»¯ÄܼìË÷¡¢Õñ¶¯ÄܼìË÷¡¢µç×ÓÄܼ¶±ð¼ìË÷¡¢½á¹¹¼ìË÷¡¢·Ö×ÓÁ¿¼ìË÷ºÍ×÷Õß¼ìË÷µÈ·½·¨£¬µÃµ½ÆøÏàÈÈ»¯Ñ§Êý¾Ý¡¢Å¨ËõÏàÈÈ»¯Ñ§Êý¾Ý¡¢Ïà±äÊý¾Ý¡¢·´Ó¦ÈÈ»¯Ñ§Êý¾Ý¡¢ÆøÏàÀë×ÓÄÜÊý¾Ý¡¢Àë×Ó¾ÛºÏÊý¾Ý¡¢ÆøÏàIRÉ«Æ×¡¢ÖÊÆ×¡¢UV/VisÉ«Æ×¡¢Õñ¶¯¼°µç×ÓÉ«Æ×µÈ¡£ |
5Â¥2010-12-31 09:05:28









»Ø¸´´ËÂ¥

ͶƱ:
30